Lung Ultrasound Assisting Weaning in Difficult-to-wean Patients (WeanUS)

November 6, 2012 updated by: Felippe Leopoldo Dexheimer Neto, Hospital Ernesto Dornelles

Daily Lung Ultrasound Assisting Weaning From Mechanical Ventilation in Difficult-to-wean Adult Patients - a Randomized Trial.

Daily lung ultrasound can help weaning from mechanical ventilation in difficult-to-wean adult patients. In this randomized trial, standardized lung ultrasound will be performed daily asssociated with standardized interventions aiming to decrease the total time in mechanical ventilation.

Study Overview

Detailed Description

This trial will be performed in two intensive care units (ICUs). After randomization, all patients in the intervention group will undergo daily lung ultrasounds before the next spontaneous breathing trial. The results from the lung ultrasound will indicate specific interventions to facilitate weaning:

  • No sign of lung sliding (ultrasound finding suggestive of pleural movement): prompt evaluation for pneumothorax or mainstream intubation will be indicated;
  • normal lung ultrasound (ultrasound A profile): the patient will be evaluated for deep vein thrombosis / pulmonary embolism and/or for reversible airway obstruction (e.g. uncontrolled asthma or COPD [Chronic Obstructive Pulmonary Disease] exacerbation)- followed by appropriate treatment. If the patient has COPD, non invasive mechanical ventilation must be used as mode of discontinuing mechanical ventilation;
  • lung ultrasound shows pulmonary edema (ultrasound B profile): cardiogenic pulmonary edema will be differentiated from acute Respiratory Distress Syndrome (ARDS) - followed by appropriate treatment (e.g. a negative fluid balance of, at least, 1000 ml before the next spontaneous breathing trial);
  • lung ultrasound shows asymmetrical patterns (ultrasound AB profile or Pulmonary Consolidation): the possibility of an uncontrolled infection will be investigated;
  • presence of simple pleural effusion: diuretics will be indicated (for a negative fluid balance of, at least, 1000 ml before the next spontaneous breathing trial) or thoracocentesis at description of the assistant team;
  • presence of complex pleural effusion: other image exam will be performed, and will be evaluated by the surgical team.

Study Type

Interventional

Enrollment (Anticipated)

128

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Rio Grande do Sul
      • Porto Alegre, Rio Grande do Sul, Brazil, 90160-093
        • Recruiting
        • Hospital Ernesto Dornelles
        • Principal Investigator:
          • Felippe L Dexheimer Neto, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Difficult to Wean;
  • 1 failure in the spontaneous breathing trial or 1 extubation failure
  • Adult patients (over 18 years old);

Exclusion Criteria:

  • Palliative Care;
  • Life expectancy under 90 days;
  • COPD Gold IV, Cirrhosis Child C, Metastatic Cancer with low performance, etc
  • Other weaning method than institutional protocol

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
No Intervention: Control Group
Experimental: Daily Lung Ultrasound

If there is no lung sliding - evaluation for pneumothorax or mainstream intubation.

If lung ultrasound shows normal pattern - search for reversible airway obstruction or venous embolism. If the patient has COPD, non invasive ventilation must be used as mode of discontinuing mechanical ventilation.

If lung ultrasound shows intersticial syndrome - evaluate the need to negativate hydric balance before the next spontaneous breathing trial.

If findings are asymmetrical - search for new or uncontrolled infection. If there is simple pleural effusion - researchers should determine a negativation of hydric balance or perform thoracocentesis.

If there are signs of complicated pleural effusion - a new image technique should be performed as evaluated by the surgical team.

If there is no lung sliding, the patient will be promptly evaluated for pneumothorax or mainstream intubation.
If the patient fails the spontaneous breathing trial and the lung ultrasound examination is normal - researchers will investigate venous thrombosis (deep vein thrombosis and/or pulmonary embolism) and rule out reversible airway obstruction. If the patient has the previous diagnosis of COPD, non invasive mechanical ventilation is indicated for facilitate weaning.
If lung ultrasound shows "B pattern" - cardiogenic pulmonary edema will be differentiated from Acute Respiratory Distress Syndrome (ARDS). If cardiogenic edema is a possibility, diuretics will be administrated (at least 40 mg of furosemide) or ultrafiltration will be performed. The main target is a negative fluid balance of, at least, 1000 ml before the next spontaneous breathing trial. Another possibility is to titrate vasodilators (at least a 20% reduction in the systolic blood pressure) before the next spontaneous breathing trial.
Other Names:
  • B Lines
If lung ultrasound shows asymmetrical findings, the occurence of new or uncontrolled infection (pulmonary or extrapulmonary) will be investigated.
Other Names:
  • AB Profile or Consolidation
If the patient has pleural effusion without ultrasonographic signs of complications (any hyperechoic pattern or complex septated pattern), researchers will administrate diuretics (at least 40 mg of furosemide in 24 hours) or increase ultrafiltration - to achieve a negative fluid balance of, at least, 1000 ml before the next spontaneous breathing trial. Another possibility is to perform pleural drainage.
If there is pleural effusion with hyperechoic or septated pattern, another image exam will be performed and evaluated by the surgical team.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Time Frame
Time in mechanical ventilation
Time Frame: from intubation until extubation success (defined as weaning from mechanical support for, at least, 48 hours) or death (days)
from intubation until extubation success (defined as weaning from mechanical support for, at least, 48 hours) or death (days)

Secondary Outcome Measures

Outcome Measure
Time Frame
Number of tracheostomies performed
Time Frame: patients follow-up will continue until weaning from mechanical support, up to 2 months
patients follow-up will continue until weaning from mechanical support, up to 2 months
Length of ICU stay
Time Frame: from icu admition until icu discharge, up to 2 months
from icu admition until icu discharge, up to 2 months
Incidence of ventilation-associated pneumonia
Time Frame: until icu discharge, up to 2 months
until icu discharge, up to 2 months
ICU's, Hospital's and 28-days mortality
Time Frame: until ICU's and hospital's discharge and 28th day from ICU admisson, with an expected average of 4 weeks
until ICU's and hospital's discharge and 28th day from ICU admisson, with an expected average of 4 weeks
Performance status at ICU's and Hospital's discharge
Time Frame: at icu's and hospital discharge, with an expected average of 4 weeks
at icu's and hospital discharge, with an expected average of 4 weeks
Correlation between findings from ultrasound and other image techniques
Time Frame: after data collection (1 year) - retrospective review
after data collection (1 year) - retrospective review
Duration of Weaning
Time Frame: From first failed spontaneous breathing trial or failed extubation until weaning from mechanical ventilation support, up to 4 weeks
From first failed spontaneous breathing trial or failed extubation until weaning from mechanical ventilation support, up to 4 weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Cassiano Teixeira, MD, PhD, Hospital Moinhos de Vento
  • Principal Investigator: Felippe L Dexheimer, MD, Hospital Ernesto Dornelles
  • Study Director: Paulo R Dalcin, MD, PhD, Federal University of Rio Grande do Sul

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

October 1, 2012

Primary Completion (Anticipated)

December 1, 2013

Study Completion (Anticipated)

June 1, 2014

Study Registration Dates

First Submitted

November 5, 2012

First Submitted That Met QC Criteria

November 6, 2012

First Posted (Estimate)

November 9, 2012

Study Record Updates

Last Update Posted (Estimate)

November 9, 2012

Last Update Submitted That Met QC Criteria

November 6, 2012

Last Verified

November 1, 2012

More Information

Terms related to this study

Other Study ID Numbers

  • 094/2011

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Difficult-to-wean Adult Patients

Clinical Trials on Abolish Lung Sliding

Subscribe